시장보고서
상품코드
1075583

세계의 임상시험 매칭 소프트웨어 시장 규모 조사 : 전개 유형별(웹 및 클라우드 기반, 온프레미스), 최종 용도별(제약 기업 및 바이오테크놀러지 기업, CRO, 의료기기 기업), 지역별 예측(2022-2028년)

Global Clinical Trials Matching Software Market Size study, by Deployment Type (Web & Cloud Based, On-premise), End Use (Pharmaceutical & Biotechnology Companies, CROs, Medical Device Firms), and Regional Forecasts 2022-2028

발행일: | 리서치사: Bizwit Research & Consulting LLP | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 임상시험 매칭 소프트웨어 시장 규모는 2021년에 약 1억 3,280만 달러로 평가되었으며, 예측 기간(2022-2028년)에 12.07% 이상의 연평균 복합 성장률(CAGR)로 성장할 것으로 예측됩니다.

임상시험 건수 증가, 감염증이나 만성질환의 유행, 임상 연구 아웃소싱 증가 등이 시장 성장을 가속하는 요인이 되고 있습니다. 의료 분야에서의 디지털화 진전, 임상연구에 대한 연구개발 자금 증가도 예측 기간에 시장 성장에 새로운 기회를 가져올 것으로 예상됩니다

세계의 임상시험 매칭 소프트웨어(Clinical Trials Matching Software) 시장에 대해 조사분석했으며, 시장 역학, 업계 분석, 시장 분석, 경쟁 등의 정보를 전해드립니다.

목차

제1장 개요

제2장 세계의 임상시험 매칭 소프트웨어 시장 정의와 범위

제3장 세계의 임상시험 매칭 소프트웨어 시장 역학

  • 세계의 임상시험 매칭 소프트웨어 시장의 영향 분석(2020-2028년)

제4장 세계의 임상시험 매칭 소프트웨어 시장 업계 분석

  • Porter's Five Forces 모델
  • PEST 분석
  • 애널리스트의 추천 사항과 결론
  • 주요 투자 기회
  • 주요 성공 전략

제5장 리스크 평가 : COVID-19의 영향

    • 업계에 대한 COVID-19의 전체적인 영향 평가
    • COVID-19 이전과 COVID-19 이후의 시장 시나리오

제6장 세계의 임상시험 매칭 소프트웨어 시장 : 전개 유형별

  • 시장 현황
  • 세계의 임상시험 매칭 소프트웨어 시장 실적 : 전개 유형별 - 잠재성 분석
  • 세계의 임상시험 매칭 소프트웨어 시장 추정과 예측(100만 달러, 2018-2028년) : 전개 유형별
  • 소프트웨어 시장에 일치하는 임상시험, 하위 부문 분석
    • 웹 및 클라우드 기반
    • 온프레미스

제7장 세계의 임상시험 매칭 소프트웨어 시장 : 최종 용도별

  • 시장 현황
  • 세계의 임상시험 매칭 소프트웨어 시장 실적 : 최종 용도별 - 잠재성 분석
  • 세계의 임상시험 매칭 소프트웨어 시장 추정과 예측(100만 달러, 2018-2028년) : 최종 용도별
  • 임상시험 매칭 소프트웨어 시장, 하위 부문 분석
    • 제약 기업 및 바이오테크놀러지 기업
    • CRO
    • 의료기기 기업

제8장 세계의 임상시험 매칭 소프트웨어 시장, 지역 분석

  • 지역 시장 현황
  • 북미
    • 미국
    • 캐나다
  • 유럽 현황
    • 영국
    • 독일
    • 프랑스
    • 스페인
    • 이탈리아
    • 기타 유럽
  • 아시아태평양 현황
    • 중국
    • 인도
    • 일본
    • 호주
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카 현황
    • 브라질
    • 멕시코
  • 기타

제9장 경쟁 정보

  • 주요 시장 전략
  • 기업 개요
    • IBM Clinical development
    • Antidote Technologies, Inc.
    • Clinical Trials Mobile Application
    • SSS International Clinical Research
    • Advarra
    • Aris Global
    • MasterControl, Inc.
    • DZS Clinical Services
    • Yprime LLC
    • Dacima Software Inc

제10장 조사 프로세스

LSH 22.05.27

Global Clinical Trials Matching Software Market is valued at approximately USD 132.8 million in 2021 and is anticipated to grow with a healthy growth rate of more than 12.07% over the forecast period 2022-2028. Clinical trial matching software help patients and their proxies (e.g., caregivers and providers) enroll in clinical trials by identifying potential trials and, in some cases, providing additional support services such as educational materials or personnel who can answer questions or assist patients. Factors such as Surge in number of clinical trials globally, Growing prevalence of infectious and chronic diseases, increase in the outsourcing of clinical research are driving the growth of market. For instance, according to registry of clinical trials ClinicalTrials.gov - during April 2020, the registered COVID-19 studies worldwide were estimated at just 260 trials and as of March 2021, the number of studies increased to 4,992 trials. Moreover, Rising digitization in healthcare sector and Increasing R& D Funding activities in Clinical Research are few other factors creating new opportunities for the market growth over the forecast period. However, high deployment & maintenance costs associated with Clinical Trials Matching Solutions are the major factors impeding the market growth over the forecast period of 2022-2028.

The regional analysis of the global Clinical Trials Matching Software market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region across the world in terms of market share owing to the ongoing clinical trials activities, high number of clinical trials activities along with the presence of a significant number of manufacturers in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate over the forecast period 2022-2028 growing healthcare expenditure in the region, increase in number of clinical trials which is increasing the demand for the software. Along with this, high government support for the clinical trials development is also driving the growth for the region over the forecasted period.

Major market player included in this report are:

IBM Clinical development

Antidote Technologies, Inc.

Clinical Trials Mobile Application

SSS International Clinical Research

Advarra

Aris Global

MasterControl, Inc.

DZS Clinical Services

Yprime LLC

Dacima Software Inc

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Deployment Type

Web & Cloud Based

On-premise

By End Use:

Pharmaceutical & Biotechnology Companies

CROs

Medical device firm

By Distribution Channel:

Supermarkets/Hypermarkets

Online Stores

Convenience Stores

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2017, 2018, 2019

Base year - 2021

Forecast period - 2022 to 2027

Target Audience of the Global Clinical Trials Matching Software Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
    • 1.2.1. Clinical Trials Matching Software Market, by Region, 2020-2028 (USD Million)
    • 1.2.2. Clinical Trials Matching Software Market, by Deployment, 2020-2028 (USD Million)
    • 1.2.3. Clinical Trials Matching Software Market, by End Use, 2020-2028 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Clinical Trials Matching Software Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Clinical Trials Matching Software Market Dynamics

  • 3.1. Clinical Trials Matching Software Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Surge in number of clinical trials globally
      • 3.1.1.2. Growing prevalence of infectious and chronic diseases.
      • 3.1.1.3. Increase in the outsourcing of clinical research
    • 3.1.2. Market Challenges
      • 3.1.2.1. High deployment & maintenance costs associated with Clinical Trials Matching Solutions.
    • 3.1.3. Market Opportunities

3.1.3.1 Rising digitization in healthcare sector

3.1.3.2 Increasing R& D Funding activities in Clinical Research.

Chapter 4. Global Clinical Trials Matching Software Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Analyst Recommendation & Conclusion
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Clinical Trials Matching Software Market, by Deployment

  • 6.1. Market Snapshot
  • 6.2. Global Clinical Trials Matching Software Market by Deployment, Performance - Potential Analysis
  • 6.3. Global Clinical Trials Matching Software Market Estimates & Forecasts by Deployment 2018-2028 (USD Million)
  • 6.4. Clinical Trials Matching Software Market, Sub Segment Analysis
    • 6.4.1. Web & Cloud Based
    • 6.4.2. On-premise

Chapter 7. Global Clinical Trials Matching Software Market, by End Use

  • 7.1. Market Snapshot
  • 7.2. Global Clinical Trials Matching Software Market by End Use, Performance - Potential Analysis
  • 7.3. Global Clinical Trials Matching Software Market Estimates & Forecasts by End Use 2018-2028 (USD Million)
  • 7.4. Clinical Trials Matching Software Market, Sub Segment Analysis
    • 7.4.1. Pharmaceutical & Biotechnology Companies
    • 7.4.2. CROs
    • 7.4.3. Medical Device Firms

Chapter 8. Global Clinical Trials Matching Software Market, Regional Analysis

  • 8.1. Clinical Trials Matching Software Market, Regional Market Snapshot
  • 8.2. North America Clinical Trials Matching Software Market
    • 8.2.1. U.S. Clinical Trials Matching Software Market
      • 8.2.1.1. Deployment breakdown estimates & forecasts, 2018-2028
      • 8.2.1.2. End Use breakdown estimates & forecasts, 2018-2028
    • 8.2.2. Canada Clinical Trials Matching Software Market
  • 8.3. Europe Clinical Trials Matching Software Market Snapshot
    • 8.3.1. U.K. Clinical Trials Matching Software Market
    • 8.3.2. Germany Clinical Trials Matching Software Market
    • 8.3.3. France Clinical Trials Matching Software Market
    • 8.3.4. Spain Clinical Trials Matching Software Market
    • 8.3.5. Italy Clinical Trials Matching Software Market
    • 8.3.6. Rest of Europe Clinical Trials Matching Software Market
  • 8.4. Asia-Pacific Clinical Trials Matching Software Market Snapshot
    • 8.4.1. China Clinical Trials Matching Software Market
    • 8.4.2. India Clinical Trials Matching Software Market
    • 8.4.3. Japan Clinical Trials Matching Software Market
    • 8.4.4. Australia Clinical Trials Matching Software Market
    • 8.4.5. South Korea Clinical Trials Matching Software Market
    • 8.4.6. Rest of Asia Pacific Clinical Trials Matching Software Market
  • 8.5. Latin America Clinical Trials Matching Software Market Snapshot
    • 8.5.1. Brazil Clinical Trials Matching Software Market
    • 8.5.2. Mexico Clinical Trials Matching Software Market
  • 8.6. Rest of The World Clinical Trials Matching Software Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. IBM Clinical development
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Deployment Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Antidote Technologies, Inc.
    • 9.2.3. Clinical Trials Mobile Application
    • 9.2.4. SSS International Clinical Research
    • 9.2.5. Advarra
    • 9.2.6. Aris Global
    • 9.2.7. MasterControl, Inc.
    • 9.2.8. DZS Clinical Services
    • 9.2.9. Yprime LLC
    • 9.2.10. Dacima Software Inc

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제